May 13, 2011
Ondine Biomedical CEO Carolyn Cross Inducted to Board of International Photodynamic Association
Category: Tinea / Fungal Infections
Ondine Biomedical CEO Carolyn Cross Inducted to Board of International Photodynamic Association
“We have spent the last 70 years using and misusing antibiotics to treat and prevent common infectious diseases” stated Carolyn Cross. “Today, we have entered an era where many bacteria have developed resistance to most antibiotics, rendering many of these drugs almost useless.
Read more on PRWeb via Yahoo! News
Leave a Reply
You must be logged in to post a comment.
